Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 4 Grant or award Director acquired 1,252 shares (grant or award)
  2. 4 Grant or award Director acquired 1,252 shares (grant or award)
  3. 4 Grant or award Director acquired 1,252 shares (grant or award)
  4. 4 Grant or award Director acquired 1,252 shares (grant or award)
  5. 8-K Event Other events
  6. 8-K Event Executive or director change · Shareholder vote results
  7. DEFA14A Proxy Proxy Materials
  8. 8-K Event Other events
  9. 4 Open-market sale Director sold 934 shares at $83.20 ($77,713)
  10. 4 Open-market sale Chief Financial Officer sold 13,293 shares at an average $86.26 ($1,146,704)
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 4 Open-market sale President & Chief Operating sold 17,598 shares at an average $84.99 ($1,495,740)
  14. 144 Insider Sale of Securities
  15. 144/A Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 4 Open-market sale Chief Legal Officer & sold 10,000 shares at $83.04 ($830,449)
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 13 of 115 · 2,300 filings